Search

A patent application by inventors from Japan focuses on a composition for treating liver dysfunction using skeletal myoblasts. The method aims to promote liver cell proliferation, tissue regeneration, and angiogenesis through cytokine production. This approach could potentially address conditions such as hepatitis, liver fibrosis, cirrhosis, and liver cancer, offering new possibilities for treating liver dysfunction. [Extracted from the article]

Researchers from the First Affiliated Hospital of Gannan Medical University in China have conducted a systematic review and meta-analysis on the use of mesenchymal stem cell exosomes (MSC-exos) for the treatment of liver fibrosis. The study found that MSC-exos significantly improved liver function, promoted the repair of damaged liver tissue, and slowed the progression of hepatic fibrosis. Additionally, the combination of MSC-exos with drug therapy was found to be more effective than MSC-exos alone. However, further experimental validations are needed before these findings can be applied in clinical treatment. [Extracted from the article]